![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Heart Septal Defects - 75 Studies Found
Terminated |
: ESCAPE Migraine Trial :
: 2005-12-16 :
|
Recruiting |
: The Effect on EPCs by Successful Cardiac Occlusion Device Implantation :
: Other: Blood samples Blood samples at baseline and 3 timepoints for EPC analysis |
Recruiting |
: PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism :
: 2005-09-09 :
|
Recruiting |
: Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure : Thrombosis : 2010-03-08 : Drug: Low molecular weight heparin Low molecular weight he |
Active, not recruiting |
: Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects : Septal Defect, Atrial : 2012-10-11 : Device: GORE® Septal Occluder The GORE® Septal Occluder consists of an implantable occluder an |
Active, not recruiting |
: Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects : Migraine : 2008-11-26 : Drug: Clopidogrel Patients will be randomized either to aspirin (80 mg/day) or aspirin (80 mg/day) + clo |
Completed |
: Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale :
: 2005-09-13 : Device: Solysafe Septal Occluder |
Recruiting |
: Hyperion™ International Registry Trial :
: 2014-08-14 : Device: ASD and PDA closure |
Completed |
: Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System :
: Device: Device Closure of Atrial Septal Defect Device Closure of Atrial Septal Defect by "Carag Bio |